| Literature DB >> 33922727 |
Hui-Ying Liu1, Chih Hsiung Kang1, Hung-Jen Wang1, Chien Hsu Chen1, Hao Lun Luo1,2, Yen-Ta Chen1, Yuan-Tso Cheng1, Po-Hui Chiang1,2.
Abstract
Preserving renal function and controlling oncological outcomes are pertinent when managing renal neoplasms. Cryoablation is the recommended treatment only for clinical T1a stage renal tumour. Here, we compared the outcomes of robot-assisted laparoscopic partial nephrectomy (RaPN) and laparoscopic cryoablation (LCA) in the treatment of patients with localised T1-T2 renal tumours. Overall, 86 patients who received RaPN and 78 patients underwent LCA were included in this study. The intraoperative, postoperative, and oncological outcomes in the LCA group were non-inferior to the RaPN group. Moreover, LCA demonstrated shorter operative time (267.45 ± 104.53 min vs. 138.56 ± 45.28 min, p < 0.001), lower blood loss (300.56 ± 360.73 mL vs. 30.73 ± 50.31 mL, p < 0.001), and slight renal function deterioration because of the reduced invasiveness, without compromising on the oncological outcomes.Entities:
Keywords: laparoscopic cryoablation; localised renal tumours; robot-assisted laparoscopic partial nephrectomy
Year: 2021 PMID: 33922727 DOI: 10.3390/diagnostics11050759
Source DB: PubMed Journal: Diagnostics (Basel) ISSN: 2075-4418